Funding for Global Research and Training
The Center for Global Health helps reduce the global burden of cancer by strengthening research capacity through funding and training. Below you will find the most recent funding opportunities that are relevant to our work.
Current Funding Opportunities
Learn more about current international cancer research and cancer control funding opportunities developed by CGH, or supported by NCI in collaboration with other NIH Institutes and Centers or research organizations.
Notice of Special Interest: Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research
Notice Number: NOT-CA-20-032
This Notice of Special Interest informs current awardees that the National Cancer Institute (NCI) is providing the opportunity for supplemental funding to stimulate interest and promote the inclusion of global (outside of the United States [U.S.]) populations, biospecimens and/or data to enhance/accelerate the progress in understanding and reducing cancer health disparities in the U.S. and globally. This Administrative Supplement is designed to support NCI-funded investigators to add global populations, biospecimens, and/or data to their currently funded projects and thereby strengthen their current research aims to better advance cancer health disparity research.
To learn more about this funding opportunity, please join us for the Global Cancer Health Disparities Research NOSI FAQ Webinar on April 15, 2020 from 2:00 – 3:00 p.m. Meeting Number: 476 879 395; Meeting Password: aGq33aZz2Z*
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD)
Notice Number: NOT-CA-20-031
The purpose of this Notice is to inform potential applicants of the special interest of the National Cancer Institute in encouraging the submission of applications that advance early detection of head and neck cancer (HNC) by applying genomics, epigenomics, transcriptomics, proteomics, and molecular signatures to clinical studies for differentiating benign lesions from malignant ones. The initiative also encourages novel basic research for HNC cancer prevention as well as the development of molecular markers to combine with current available HNC detection methods for increasing sensitivity and specificity.
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments
This Notice seeks to inform potential applicants of the interest of the National Cancer Institute (NCI) in supporting implementation research related to cancer prevention and control in low- and middle-income countries (LMICs) and in low-resource settings. NCI encourages applications that pursue innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines in low-resource settings. The research projects on which these applications will be based should be focused on dissemination and implementation research for the primary and secondary prevention of cancer in LMICs and/or in populations facing conditions of vulnerability in high-income countries.
Interested applicants must submit applications for this initiative using one of the following Dissemination and Implementation Research in Health funding opportunity announcements: PAR-19-274 (R01 Clinical Trial Optional); PAR-19-275 (R21 Clinical Trial Optional); PAR-19-276 (R03 Clinical Trial Not Allowed). For more information visit: https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-025.html.
Notice of Intent to Publish: Strengthening Institutional Capacity to Conduct Global Cancer Research (D43)
The National Cancer Institute intends to publish the Strengthening Institutional Capacity to Conduct Global Cancer Research (D43) funding opportunity announcement (FOA) as a request for applications that will invite applications from U.S.-based cancer-research intensive institutions who propose research training programs working in collaboration with a low-and middle-income country institution to strengthen capacity to conduct global research. The overarching goal of this research training program is to provide investigators and health professionals with the scientific expertise, mentorship, and leadership skills needed to conduct innovative and collaborative global research projects that will contribute to the advancement of basic, clinical, translational, and population-based cancer research. This FOA is expected to be published in the NIH Guide in the winter of 2020, with expected application due dates in spring 2020 and winter 2021.
The purpose of this funding opportunity announcement is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. PAR-19-194 (R21 for early stage research); PAR-19-193 (R01 for mature projects). Examples of Applications: (RO1, R21s).
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (Clinical Trial Optional)
These funding opportunities encourage Small Business Innovation Research (SBIR and STTR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the U.S. PAR-18-801 (R43/R44); PAR-18-802 (R41/42). For more information about these funding opportunities, download presentations from the NCI SBIR-CGH Joint Informational Webinar: SBIR-CGH Webinar1; SBIR-CGH Webinar2.
Note: Direct-to-Phase II is allowed for PAR-18-801 https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-003.html.
Dissemination and Implementation Research in Health (Clinical Trial Optional)
This funding opportunity encourages research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices into public health, clinical practice, and community settings. PAR-19-274 (R01); PAR-19-275 (R21).
This funding opportunity encourages research grant applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement evidence-based health practices for public health, clinical practice, and community settings.
International Research Scientist Development Award (K01)
This funding opportunity supports intensive, mentored research career development for early stage investigators committed to a cancer research career. PAR-18-539 (Independent clinical trial not allowed). PAR-18-540 (Independent clinical trial required). For additional information, please visit Frequently Asked Questions for the International Research Scientist Development Award.
This funding opportunity supports U.S.- Caribbean collaborative research to develop or extend cohort or surveillance studies on chronic disease in the Caribbean region, aligned with existing, publicly available U.S. datasets.
These funding opportunities highlight research initiatives that align with the efforts of the Cancer Moonshot. Supported with existing or 21st Century Cures Act funds, featured announcements include open funding opportunities.
This funding opportunity supports high quality scientific conferences that are relevant to the NIH's mission and to the public health.
Previously Funded Initiatives
Learn more about CGH’s previously funded research grants and initiatives. Download list of CGH previously funded initiatives.
Learn more about training opportunities available to U.S. and international students, scientists, and health care professionals.
The Short-Term Scientist Exchange Program at the Center for Global Health, National Cancer Institute, promotes collaborative research between researchers at the NCI and foreign cancer researchers.
This program offers two short-term cancer prevention training courses in Rockville, MD to international scientists and healthcare professionals from LMICs and the All-Ireland Cancer Consortium (AICC).